PUMA BIOTECHNOLOGY, INC. Operating Leases, Future Minimum Payments, Due Thereafter
PUMA BIOTECHNOLOGY, INC. (PBYI) had Operating Leases, Future Minimum Payments, Due Thereafter of $13.30 million as of 2018-12-31, per its 10-Q filed 2019-11-07.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueThereafter · last filed 2019-11-07
- 2018-12-31: Operating Leases, Future Minimum Payments, Due Thereafter $13.30M; Operating Leases, Future Minimum Payments, Due Thereafter as first filed $18.93M.
- 2017-12-31: Operating Leases, Future Minimum Payments, Due Thereafter $24.09M.
- 2016-12-31: Operating Leases, Future Minimum Payments, Due Thereafter $24.73M.
- 2015-12-31: Operating Leases, Future Minimum Payments, Due Thereafter $29.38M.
| Period end | Operating Leases, Future Minimum Payments, Due Thereafter | Operating Leases, Future Minimum Payments, Due Thereafter as first filed |
|---|---|---|
| 2018-12-31 | $13.30M 10-Q · filed 2019-11-07 | $18.93M 10-K · filed 2019-03-01 |
| 2017-12-31 | $24.09M 10-K · filed 2018-03-09 | |
| 2016-12-31 | $24.73M 10-K · filed 2017-03-01 | |
| 2015-12-31 | $29.38M 10-K · filed 2016-02-29 | |
| 2013-12-31 | $308.00K 10-K · filed 2014-03-03 | |
| 2012-12-31 | $1.78M 10-K · filed 2013-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |